2023 Specialty Day All-Access Pass-The New/Emerging Blood-Based Formulations Beyond PRP

The New/Emerging Blood-Based Formulations Beyond PRP

Video Transcription

Video Summary

In this video, Dr. Nick Puizzi discusses the current state and future potential of platelet-rich plasma (PRP) therapy in orthopedics. PRP has been in use for 70 years but has seen slow progress in terms of preparation methods and understanding its mechanism of action. The main classification for PRP is based on the concentration of leukocytes, but this is still uncertain and lacks consensus. The cost-effectiveness of PRP is also a challenge, with total joint replacement often being more cost-effective. The future of PRP lies in understanding exosomes and their therapeutic potential, as well as finding ways to isolate and use them in specific formulations. However, this is still in early stages and mainstream use is far off. In conclusion, Dr. Puizzi emphasizes the importance of better understanding disease targets and identifying responders to current treatments. The journey towards optimizing PRP therapy is long, but progress will be made over time.<br />Credits: Dr. Nick Puizzi (speaker).

Asset Caption

Nicolas Piuzzi, M.D.

Keywords

platelet-rich plasma

PRP therapy

orthopedics

leukocytes concentration

cost-effectiveness